Jamie Christensen - 04 Jan 2023 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
EVP, Chief Scientific Officer
Signature
/s/ Reena Desai, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
04 Jan 2023
Net transactions value
-$90,823
Form type
4
Filing time
05 Jan 2023, 16:13:12 UTC
Previous filing
20 Dec 2022
Next filing
19 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale $90,823 -1,949 -1.9% $46.60 100,123 04 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 3, 2020.